Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus.

Area of Science:

• Gastroenterology
• Oncology
• Molecular Biology

Background:

• Proto-oncogene activation is linked to various cancers.
• The role of oncogenes in esophageal adenocarcinoma remains unclear.

Purpose of the Study:

• To investigate the expression of specific oncogenes and the onco-suppressor gene p53 in esophageal adenocarcinoma and Barrett's esophagus.
• To determine the potential role of these genetic alterations in the pathogenesis of esophageal adenocarcinoma.

Main Methods:

• Immunohistochemical staining of mucosal samples from 15 esophageal adenocarcinoma patients and 15 Barrett's esophagus patients.
• Analysis of oncogene-associated proteins: c-erbB2 (external and internal domains), c-src, c-ras, c-myc, c-fos, c-jun, and p53.
• Comparison of protein expression in tumor, Barrett's epithelium, and adjacent normal gastric mucosa.

Main Results:

• High frequency of c-erbB2 expression (both domains) in esophageal adenocarcinomas (11/15).
• Significant nuclear staining for p53 in 7/15 tumors.
• c-erbB2 was also frequently expressed in Barrett's epithelium (9/15), with lower frequencies for c-src, c-ras, and c-jun.
• Weak c-erbB2 expression noted in 2/15 normal gastric mucosa samples; no other oncogenes detected.

Conclusions:

• Aberrant expression of c-erbB2 and p53 may play a crucial role in the development of esophageal adenocarcinoma.
• The frequent presence of c-erbB2 in Barrett's mucosa suggests its involvement in the progression from Barrett's to adenocarcinoma.
• These findings highlight potential therapeutic targets for esophageal adenocarcinoma.